ATRX and central nervous system cancer: In comparison to other studies in which ATRX was found to be mutated only rarely in adult primary GBM, but frequently found in younger adults with lower-grade glioma (WHO grade II/III) [31], we found a high frequency at 30 years that decreases in elderly patients.